Medicare Enrolled

Dr. Andrew Pazandak, MD

Ophthalmology · Irving, TX
Low-engagement
3100 N MACARTHUR BLVD, Irving, TX 75062
9722586400
In practice since 2014 (12 years)
NPI: 1417375775 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pazandak from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pazandak? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pazandak

Dr. Andrew Pazandak is an ophthalmology in Irving, TX, with 12 years in practice.

Between the years covered by Open Payments, Dr. Pazandak received a total of $3,768 from 27 pharmaceutical and/or device companies across 111 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pazandak is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice$ $3,768 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$3,768
Total received (2018-2024)
Avg $538/year across 7 years
Top 30% in TX for ophthalmology
27
Companies
111
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,768 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$543
2023
$478
2022
$382
2021
$448
2020
$692
2019
$179
2018
$1,047

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Alcon Research Ltd
$705
Ivantis, Inc
$490
Allergan, Inc.
$426
Johnson & Johnson Surgical Vision, Inc.
$260
Alcon Vision LLC
$231
Novartis Pharmaceuticals Corporation
$190
ABBVIE INC.
$151
Aerie Pharmaceuticals, Inc.
$139
Oyster Point Pharma, Inc.
$137
Alcon Laboratories Inc
$120
Sight Sciences, Inc.
$109
BioTissue Holdings, Inc.
$95
Bausch & Lomb Americas Inc.
$87
Kala Pharmaceuticals, Inc.
$72
RxSight Inc
$70
Rayner Intraocular Lenses Limited
$63
BIOTISSUE HOLDINGS, INC.
$60
BIOTISSUE HOLDINGS INC.
$55
Allergan Inc.
$53
Ocular Therapeutix, Inc.
$52
THE CAMERON-EHLEN GROUP, INC.
$49
Sun Pharmaceutical Industries Inc.
$40
EYEVANCE PHARMACEUTICALS LLC
$34
SUN PHARMACEUTICAL INDUSTRIES INC.
$25
Harrow Eye, LLC
$24
GLAUKOS CORPORATION
$17
Eyevance Pharmaceuticals LLC
$14
Top 3 companies account for 43.0% of total payments
Associated products mentioned in payments ›
AcrySof IQ PanOptix · CATALYS SYSTEM · COMBIGAN · Cequa · Clareon · CyPass · DEXTENZA · DURYSTA · Flarex · Hydrus · Hydrus Microstent · INVELTYS · KXL SYSTEM · LUMIGAN · MIEBO · OMNI Surgical System · Omidria · PROKERA · Pred-Moxi-Brom · RESTASIS · RESTASIS MULTIDOSE · RXSIGHT CONTACT LENS · Rhopressa · Rocklatan · TYRVAYA · Tecnis Simplicity · TobraDex ST · Tobradex ST · VERITAS Vision System · VEVYE · VUITY · VYZULTA · Wavelight · Wavelight Refractive Suite · XEN · XIIDRA · rhopressa
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a ophthalmology in Irving?
Compare ophthalmologys in the Irving area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologys nearby

Geographic Context

Ophthalmologys within 10 mi
316
Per 100K population
12.1
County median income
$74,149
Nearest hospital
BAYLOR SCOTT & WHITE MEDICAL CENTER AT IRVING
1.6 mi

Data Sources

Provider Registry✓ NPPESWeekly updates
Medicare Enrollment✓ PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments✓ Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Pazandak is a ophthalmology, and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Pazandak receive payments from pharmaceutical companies?
Yes. Dr. Pazandak received a total of $3,768 from 27 companies across 111 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Pazandak) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Ophthalmologys in Irving
Browse ophthalmologys in Irving ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologys in TX
Ophthalmologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologys in TX
Which TX ophthalmologys receive the most from drug and device companies.
By company
Alcon Research Ltd Payments to Doctors
See all physicians who received payments from Alcon Research Ltd.
By company
Ivantis, Inc Payments to Doctors
See all physicians who received payments from Ivantis, Inc.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc..
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →